|
Àü¼¼°è µµ¸ÅÀεéÀÇ Á¤º¸±³·ùÀÇ
ÀåÀÎ Á¦13ȸ 2010³â
IFPW ¼¿ïÃÑȸ°¡ ÀÌÁ¦ 270¿©ÀÏ ¾ÕÀ¸·Î ´Ù°¡¿Ô´Ù.
µµÇùÀº Áö³ 2008³â ´ëȸ À¯Ä¡È°µ¿À» ½ÃÀÛÀ¸·Î Áö³
5¿ù 26ÀÏ Á¤½Ä IFPW ¼¿ïÃÑȸ
ÁغñÀ§¿øÈ¸(LOC;Local Organization Committee)¸¦ ±¸¼º•Ȱµ¿Çϰí ÀÖÀ¸¸ç IFPW »ç¹«±¹°ú Áö¿ªÀÚ¹®À§¿øÈ¸(RAB; Regional Adviosory Bord)¿Í À¯±âÀûÀÎ °ü°è¸¦ ÅëÇØ ÃÑȸÁغñ¿¡ ¹ÚÂ÷¸¦ °¡Çϰí
ÀÖ´Ù. ÇöÀç±îÁöÀÇ ÁøÇà»óȲ°ú °èȹ ¹× IFPW ¼¿ïÃÑȸÀÇ
ÀÇÀǸ¦ ¾Ë¾Æº»´Ù.
|
1.
IFPW[±¹Á¦ÀǾàǰµµ¸Å¿¬¸Í] ÇöȲ
¡á
IFPW¶õ?
±¹Á¦ÀǾàǰµµ¸Å¿¬¸Í[International Federation of Pharmaceutical Wholesalers]À¸·Î ¼¼°è
ÀǾàǰµµ¸ÅÀ¯Åë¾÷ »ç¾÷ÀÚµéÀÇ ±¹Á¦ÇмúȸÀÇ ¹× ¼¼°èÀǾàǰ½ÃÀå ÇöȲ ÆÄ¾Ç, ÀǾàǰ»ê¾÷ Àü¸Á µîÀÇ Á¤º¸±³·ù
´Üü
(1) IFPW »ç¾÷ ¸ñÀû
- ¼¼°èÀǾàǰ»ê¾÷ ÇöȲ ¹× Àü¸Á ¿¬±¸
¹ßÇ¥
- ¼¼°èÀǾàǰÀ¯Åë½ÃÀåÇöȲ ¹× ¹ßÀü¹æÇâ
¿¬±¸ ¹ßÇ¥
- ¼¼°èÀǾàǰÀ¯Åë½ÃÀå Åë°èÁ¤º¸ ±³·ù
µî
- 2³â¸¶´Ù 9¿ù°æ Á¤±âÃÑȸ °³ÃÖ
(2) IFPW ÀÓ¿ø ÇöȲ
- IFPW´Â
2008³â 9¿ù ÀÓ¿ø°³¼±À» ÅëÇØ ÀÌ»çȸ ÀÇÀå¿¡ ¸®¾Ï ÇÇÃ÷Á¦·²µå À¯³ªÀÌÆ¼µå µå·°(United Drug. ¾ÆÀÏ·£µå) ´ëÇ¥ÀÌ»ç, ºÎÀÇÀå¿¡ Ÿī¾ÆÅ° ¸¶Ã÷´Ù´Ï ÅäÈ£¾àǰ(Toho Pharmaceutical.
ÀϺ») ȸÀåÀÌ °¢°¢ ¼±ÃâµÊ. ¶Ç ¹Ì±¹, ¿µ±¹, µ¶ÀÏ µî °¢±¹¿¡¼
9¸íÀÇ À̻縦 µÎ°í ÀÖÀ½.
- ¶ÇÇÑ IFPW ½Ç¹«¸¦ ´ã´çÇÏ´Â »ç¹«±¹(¹Ì±¹ ¹öÁö´Ï¾Æ À§Ä¡)Àº ¸¶Å© Æä¸®½¬ »ç¹«ÃÑÀå(îñÄ«µð³¯ ÃÖ°í °æ¿µÀÚ)¿Í Å©¸®½ºÅäÆÛ °ÔÃ÷ ºÎ»ç¹«ÃÑÀåÀÌ È°µ¿Çϰí ÀÖÀ½.
(3) ȸ¿ø»ç ÇöȲ
- Àü¼¼°è 30¿©°³±¹¿¡¼ ÀÚ±¹Çùȸ, °³º° µµ¸Åȸ»ç, Á¦¾à»ç, À¯Åë°ü·Ã ¼ºñ½º¾÷üÀÇ ÇüÅ·Πȸ¿øÈ°µ¿.
(4) ȸ¿ø»ç Á¾·ù

2. IFPW ¼¿ïÃÑȸ
¡á ¼¿ïÃÑȸ °³¿ä
(1) ÀÏ
ÀÚ :
2010³â 9¿ù
13-15ÀÏ
(2) Àå
¼Ò :
ºñÁî´Ï½º Æ÷·³ ¹× ¸ÞÀÎ
¼÷¼Ò - ¼¿ï ½Å¶óÈ£ÅÚ
°¢Á¾ ¸¸Âù - ½Å¶óÈ£ÅÚ ¿µºó°ü, Çѱ¹ °ü±¤¸í¼Ò,
ÀüÅ뿬ȸÀå µî
(3) ÁÖ
Á¦ :
ÀǾàǰµµ¸Å¾÷:ÀǾàǰÀ¯Åë»ê¾÷ÀÇ Çʼö¿ªÇÒ
(±Þº¯Çϴ ȯ°æ¼Ó¿¡¼ ¾ÈÀüÇϰí
È¿°úÀûÀÎ ÀǾàǰ °ø±Þ)
WHOLESALERS: THE VITAL LINK IN HEALTHCARE
(Safe, efficient, continuous access to medicines in a challenging
environment)
(4)¿¥ºí·³

(5)ÇÁ·Î±×·¥

(6)ºñÁö´Ï½º ÇÁ·Î±×·¥
¼Ò°³ 
(7)¿ª´ë ÃÑȸ Âü¼®ÀÚ ºÐÆ÷µµ
(8) ¼¿ïÃÑȸ Áغñ À§¿øÈ¸
ÇöȲ
- ÁغñÀ§¿øÈ¸(LOC;Local Organizing Committee) : ±¹³» ¿î¿µÁ¶Á÷ 
-Áö¿ªÀÚ¹®À§¿øÈ¸(Regional Advisory Board;RAB) : ¾Æ½Ã¾ÆÁö¿ª ÀÚ¹®±â°ü

(9) ÃÑȸ ¿¹»ê±Ô¸ð

¡ã ¼öÀÔ |

¡ã ÁöÃâ |
3.
IFPW ¼¿ïÃÑȸ
À¯Ä¡ ÀÇÀÇ
(1) Çѱ¹ÀÇ ÀǾàǰÀ¯Åë»ê¾÷ À§»ó
Á¦°í
(2) ÇØ¿Ü ±Û·Î¹úÁ¦¾à»ç¿¡ Çѱ¹
ÀǾàǰÀ¯Åëü°è °æÀï·Â Á¦°í
(3) ¼¼°è ÀǾàǰÁ¤º¸ ±³·ù
(4) ÀǾàǰÀ¯Åë»ê¾÷À» À§ÇÑ ±¹Á¦
ºñÁî´Ï½ºÈ¸ÀÇ À¯Ä¡
(5) Çѱ¹ È«º¸¿¡ ±â¿©
4.
ÇâÈÄ
ÀÏÁ¤
2010³â
1¿ù
¿¬ÀÚ ¹× ¼¼¹Ì³ªÁÖÁ¦ È®Á¤
2¿ù ȨÆäÀÌÁö(±¹³»/±¹¿Ü) ±¸Ãà
¿Ï·á
1Â÷ ¾È³»¹® ¹ß¼Û
3¿ù LOC »ç¹«½Ç
°³¼³
4¿ù 2Â÷ RABȸÀÇ °³ÃÖ(¿µ»óȸÀÇ)
5¿ù Á¶±âµî·Ï
¸¶°¨/ÀϹݵî·Ï ½ÃÀÛ
9¿ù 13-15ÀÏ
¼¿ïÃÑȸ °³ÃÖ
¡ãÁö³
11¿ù 18ÀÏ 2010 IFPW
¼¿ïÃÑȸ D-300À» ±â³äÇÏ¿© ÇâÈÄ ÀÏÁ¤À» ÁغñÇϴ ȸÀǰ¡ °³ÃֵƴÙ. (ÁËÃøºÎÅÍ Çã°¿ø ÃѰýÁö¿øº»ºÎÀå, ¾öÅÂÀÀ »ç¹«ÃÑÀå, ÁÖ¸¸±æ ÁغñÀ§¿øÀå, ½Å³²¼ö
ÀçÁ¤Áö¿øÀ§¿øÀå |